SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Fazli Wahid, Taous Khan, You Young Kim, MicroRNA and diseases: Therapeutic potential as new generation of drugs, Biochimie, 2014, 104, 12

    CrossRef

  2. 2
    Andrew R. Mendelsohn, James W. Larrick, Partial Reversal of Skeletal Muscle Aging by Restoration of Normal NAD+Levels, Rejuvenation Research, 2014, 17, 1, 62

    CrossRef

  3. 3
    Nathan L. Price, Cristina M. Ramírez, Carlos Fernández-Hernando, Relevance of microRNA in metabolic diseases, Critical Reviews in Clinical Laboratory Sciences, 2014, 1

    CrossRef

  4. 4
    Duarte M. S. Ferreira, André L. Simão, Cecília M. P. Rodrigues, Rui E. Castro, Revisiting the metabolic syndrome and paving the way for microRNAs in non-alcoholic fatty liver disease, FEBS Journal, 2014, 281, 11
  5. 5
    Juan L. García-Rodríguez, Lucía Barbier-Torres, Sara Fernández-Álvarez, Virginia Gutiérrez-de Juan, María J. Monte, Emina Halilbasic, Daniel Herranz, Luis Álvarez, Patricia Aspichueta, Jose J.G. Marín, Michael Trauner, Jose M. Mato, Manuel Serrano, Naiara Beraza, María Luz Martínez-Chantar, SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling, Hepatology, 2014, 59, 5
  6. 6
    M. Rokavec, H. Li, L. Jiang, H. Hermeking, The p53/miR-34 axis in development and disease, Journal of Molecular Cell Biology, 2014, 6, 3, 214

    CrossRef

  7. 7
    Zi-Feng Zhang, Shao-Hua Fan, Yuan-Lin Zheng, Jun Lu, Dong-Mei Wu, Qun Shan, Bin Hu, Troxerutin improves hepatic lipid homeostasis by restoring NAD+-depletion-mediated dysfunction of lipin 1 signaling in high-fat diet-treated mice, Biochemical Pharmacology, 2014, 91, 1, 74

    CrossRef